1型糖尿病首次及后续心血管疾病事件的风险因素:DCCT/EDIC研究
基于DCCT/EDIC研究中1441例1型糖尿病患者,中位随访29年,239人发生421次CVD事件,120人发生149次MACE。年龄是急性心梗、静息心梗、卒中和PTCA/CABG的最强风险因素,血糖是CVD死亡、心衰和心绞痛的最强风险因素。HbA1c是首次和后续CVD事件的最强可干预风险因素。
要点
- 年龄是急性心梗、静息心梗、卒中和PTCA/CABG的最强风险因素。
- 血糖是CVD死亡、心衰和心绞痛的最强风险因素。
- HbA1c是首次及后续CVD事件的最强可干预风险因素。
核心结论
- 推荐强化血糖管理以降低1型糖尿病首次CVD事件风险。
- 首次事件后,最佳血糖控制可能降低复发CVD事件风险,应予维持。
研究设计与样本
- 分析DCCT/EDIC研究中1441例1型糖尿病参与者的CVD事件,按类型或复合结局分别评估,采用比例率模型和条件模型分析风险因素与CVD结局的关联。
主要发现
- 中位随访29年,239例参与者发生421次CVD事件,120例发生149次MACE。
- 年龄是急性心梗、静息心梗、卒中和PTCA/CABG的最强风险因素,血糖是CVD死亡、心衰和心绞痛的最强风险因素。
- 血糖对急性心梗和PTCA/CABG为第二强风险因素,对卒中为第三强风险因素,与静息心梗无关联。
- HbA1c是首次CVD事件的最强可干预风险因素:CVD的HR 1.38(95%CI 1.21,1.56)/HbA1c每升高1%;MACE的HR 1.54(95%CI 1.30,1.82)。
- HbA1c也是后续CVD事件的风险因素:CVD的IR 1.28(95%CI 1.09,1.51);MACE的IR 1.89(95%CI 1.36,2.61)。
关键数值与推荐
- HbA1c每升高1%,首次CVD事件HR 1.38(95%CI 1.21,1.56),首次MACE HR 1.54(95%CI 1.30,1.82)。
- HbA1c每升高1%,后续CVD事件IR 1.28(95%CI 1.09,1.51),后续MACE IR 1.89(95%CI 1.36,2.61)。
临床怎么用
- 推荐强化血糖管理以降低1型糖尿病首次CVD事件风险。
- 首次CVD事件后,最佳血糖控制可能降低复发CVD事件风险,应予维持。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Diabetes Control and Complications Trial (DCCT) and its observational follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) demonstrated the dominant role of glycemia, second only to age, as a risk factor for a first cardiovascular event in type 1 diabetes (T1D). We now investigate the association between established risk factors and the total cardiovascular disease (CVD) burden, including subsequent (i.e., recurrent) events. RESEARCH DESIGN AND METHODS: CVD events in the 1,441 DCCT/EDIC participants were analyzed separately by type (CVD death, acute myocardial infarction [MI], stroke, silent MI, angina, percutaneous transluminal coronary angioplasty/coronary artery bypass graft [PTCA/CABG], and congestive heart failure [CHF]) or as composite outcomes (CVD or major adverse cardiovascular events [MACE]). Proportional rate models and conditional models assessed associations between risk factors and CVD outcomes. RESULTS: Over a median follow-up of 29 years, 239 participants had 421 CVD events, and 120 individuals had 149 MACE. Age was the strongest risk factor for acute MI, silent MI, stroke, and PTCA/CABG, while glycemia was the strongest risk factor for CVD death, CHF, and angina, second strongest for acute MI and PTCA/CABG, third strongest for stroke, and not associated with silent MI. HbA1c was the strongest modifiable risk factor for a first CVD event (CVD: HR 1.38 [95% CI 1.21, 1.56] per 1% higher HbA1c; MACE: HR 1.54 [1.30, 1.82]) and also for subsequent CVD events (CVD: incidence ratio [IR] 1.28 [95% CI 1.09, 1.51]; MACE: IR 1.89 [1.36, 2.61]). CONCLUSIONS: Intensive glycemic management is recommended to lower the risk of initial CVD events in T1D. After a first event, optimal glycemic control may reduce the risk of recurrent CVD events and should be maintained.
引用
- Bebu I, Schade D, Braffett B, et al. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care. 2020. PMID: 32001614. doi:10.2337/dc19-2292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。